Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 211853

1.

Bone and Soft Tissue Pathology: SC02-1 CARTILAGE TUMORS.

Bertoni F, Bacchini P.

Pathology. 2014 Oct;46 Suppl 2:S5. doi: 10.1097/01.PAT.0000454060.23525.07.

PMID:
25188184
[PubMed - in process]
2.

Pediatric and Perinatal Pathology: SY21-5 EXPRESSION OF MIR-210, MIR130A, MIR-200B IN TUMORS OF THE ADRENAL CORTEX OF PEDIATRIC PATIENTS.

Perezpeña-Diazconti M, Perez-Velasquez R, Valencia-Mayoral P, Eguía-Aguilar P, Arenas-Huertero F.

Pathology. 2014 Oct;46 Suppl 2:S35-6. doi: 10.1097/01.PAT.0000454207.66855.7b.

PMID:
25188149
[PubMed - in process]
3.

Histologic correlation of expression of Ki-67 in squamous cell carcinoma of the glottis according to the degree of cell differentiation.

Bonhin RG, de Carvalho GM, Guimarães AC, Chone CT, Crespo AN, Altemani AM, Amstalden EM.

Braz J Otorhinolaryngol. 2014 Jul-Aug;80(4):290-5. doi: 10.1016/j.bjorl.2014.05.016. Epub 2014 Jun 11.

PMID:
25183178
[PubMed - in process]
Free Article
4.

Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation.

Kordelas L, Verheyen J, Beelen DW, Horn PA, Heinold A, Kaiser R, Trenschel R, Schadendorf D, Dittmer U, Esser S; Essen HIV AlloSCT Group.

N Engl J Med. 2014 Aug 28;371(9):880-2. doi: 10.1056/NEJMc1405805. No abstract available.

PMID:
25162903
[PubMed - indexed for MEDLINE]
Free Article
5.

Translational Genomics and Head and Neck Cancer: Toward Precision Medicine.

Razzouk S.

Clin Genet. 2014 Aug 21. doi: 10.1111/cge.12487. [Epub ahead of print]

PMID:
25143247
[PubMed - as supplied by publisher]
6.

Therapy-resistant metastasizing anaplastic spermatocytic seminoma: a cytogenetic hybrid: a case report.

Mikuz G, Böhm GW, Behrend M, Schäfer G, Colecchia M, Verdorfer I.

Anal Quant Cytopathol Histpathol. 2014 Jun;36(3):177-82.

PMID:
25141494
[PubMed - indexed for MEDLINE]
7.

Value of urinary survivin as a diagnostic marker in bladder cancer.

Abd El-Hakim TF, El-Shafie MK, Abdou AG, Azmy RM, El-Naidany SS, Badr El-Din MO.

Anal Quant Cytopathol Histpathol. 2014 Jun;36(3):121-7.

PMID:
25141488
[PubMed - indexed for MEDLINE]
8.

Cancer of unknown primary site.

Varadhachary GR, Raber MN.

N Engl J Med. 2014 Aug 21;371(8):757-65. doi: 10.1056/NEJMra1303917. Review. No abstract available.

PMID:
25140961
[PubMed - indexed for MEDLINE]
9.

HER2-positive breast cancer, intrinsic subtypes, and tailoring therapy.

Ellis MJ.

J Natl Cancer Inst. 2014 Aug 19;106(8). pii: dju212. doi: 10.1093/jnci/dju212. Print 2014 Aug. No abstract available.

PMID:
25139535
[PubMed - indexed for MEDLINE]
10.

Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancer.

Prat A, Carey LA, Adamo B, Vidal M, Tabernero J, Cortés J, Parker JS, Perou CM, Baselga J.

J Natl Cancer Inst. 2014 Aug 19;106(8). pii: dju152. doi: 10.1093/jnci/dju152. Print 2014 Aug.

PMID:
25139534
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

[Gallbladder cancer with elevated serum α-fetoprotein, α-fetoprotein-L3, and human chorionic gonadotropin levels].

Goto A, Ishimine Y, Hirata T, Naito T, Yabana T, Adachi T, Kondo Y, Kasai K.

Gan To Kagaku Ryoho. 2014 Aug;41(8):1021-5. Review. Japanese.

PMID:
25132038
[PubMed - indexed for MEDLINE]
12.

[Successful treatment of advanced sigmoid colon cancer with liver metastases with cetuximab monotherapy as first-line treatment-a case report].

Harada K, Hatanaka K, Kinoshita K, Kawamoto Y, Yamato H, Ogawa K, Yamamoto Y, Naruse H.

Gan To Kagaku Ryoho. 2014 Jul;41(7):897-900. Japanese.

PMID:
25131880
[PubMed - indexed for MEDLINE]
13.

[Carcinoma unknown primary-clinical practice].

Onozawa Y.

Gan To Kagaku Ryoho. 2014 Jul;41(7):799-803. Review. Japanese.

PMID:
25131862
[PubMed - indexed for MEDLINE]
14.

Hormone therapy can wait in PSA-only relapse.

Schmidt C.

J Natl Cancer Inst. 2014 Aug 13;106(8). pii: dju278. doi: 10.1093/jnci/dju278. Print 2014 Aug. No abstract available.

PMID:
25122737
[PubMed - indexed for MEDLINE]
15.

Identifying cancer mutations as therapeutic targets.

Azvolinsky A.

J Natl Cancer Inst. 2014 Aug 13;106(8). pii: dju276. doi: 10.1093/jnci/dju276. Print 2014 Aug. No abstract available.

PMID:
25122735
[PubMed - indexed for MEDLINE]
16.

Back to the basis: breast cancer heterogeneity from an etiological perspective.

Weigelt B, Reis-Filho JS.

J Natl Cancer Inst. 2014 Aug 12;106(8). pii: dju211. doi: 10.1093/jnci/dju211. Print 2014 Aug. No abstract available.

PMID:
25118204
[PubMed - indexed for MEDLINE]
17.

How many etiological subtypes of breast cancer: two, three, four, or more?

Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME.

J Natl Cancer Inst. 2014 Aug 12;106(8). pii: dju165. doi: 10.1093/jnci/dju165. Print 2014 Aug. Review.

PMID:
25118203
[PubMed - indexed for MEDLINE]
18.

Molecular diagnosis of soft tissue neoplasia: clinical applications and recent advances.

Hameed M.

Expert Rev Mol Diagn. 2014 Aug 9:1-17. [Epub ahead of print]

PMID:
25109831
[PubMed - as supplied by publisher]
19.

When is it time to stop being checked for prostate cancer? The answer depends on your current health and your level of concern about cancer.

[No authors listed]

Harv Mens Health Watch. 2014 Apr;18(9):6. No abstract available.

PMID:
25108922
[PubMed - indexed for MEDLINE]
20.

Breast cancer subtypes can be a predictor of pathologic complete response and survival in the neoadjuvant setting for T4 noninflammatory breast cancer.

Gülben K, Berberoğlu U, Kinaş V, Başkan E.

Acta Chir Belg. 2014 May-Jun;114(3):153-9.

PMID:
25102703
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk